Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase 3 ...
Researchers have identified a signaling pathway by which aspirin can inhibit colorectal cancer. LMU researchers have identified a signaling pathway by which aspirin can inhibit colorectal cancer.
Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...
LMU researchers have identified a signaling pathway by which aspirin can inhibit colorectal cancer. Colorectal cancer (bowel cancer) is the third most common form of cancer worldwide, with around 1.9 ...
Healio: Low-dose aspirin reduces colorectal cancer recurrence for patients with PI3K mutations
Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in ...
The American Journal of Managed Care: Low-Dose Aspirin Cuts Recurrence Risk in PI3K-Altered Colorectal Cancer
“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which is very positive,” says Anna Martling.
Everyday Health: For Some Colorectal Cancer Survivors, Aspirin May Slash Recurrence Risk
In a new study, low-dose daily aspirin roughly halved the risk of cancer coming back for patients whose tumors had a specific genetic mutation. Daily low-dose aspirin halves the risk of colorectal ...
Recent research from Massachusetts General Hospital and Harvard Medical School has uncovered aspirin‘s surprising protective effect against colorectal cancer, particularly among individuals with less ...